To include your compound in the COVID-19 Resource Center, submit it here.

Apellis prices $150M IPO

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) raised $150 million after market hours on Nov.

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE